ChemoCentryx Receives $29,840,000 Series D Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62d0cfc4-5fbe-47d3-9762-9f9a5966d3b3&Preview=1 -
Date
3/22/2007 -
Company Name
ChemoCentryx -
Mailing Address
850 Maude Avenue Mountain View, CA 94043 -
Company Description
ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. -
Website
http://www.chemocentryx.com -
Transaction Type
Venture Equity -
Transaction Amount
$29,840,000 -
Transaction Round
Series D -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Alta Partners -
Venture Investor
GIMV -
Venture Investor
HBM Bioventures -
Venture Investor
OrbiMed
